risperidone
Generic: risperidone
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
risperidone
Generic Name
risperidone
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
TABLET
Routes
Active Ingredients
risperidone 2 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-264
Product ID
71610-264_734267df-c692-446a-ae8b-47462213b1ba
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA201003
Listing Expiration
2026-12-31
Marketing Start
2014-03-28
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610264
Hyphenated Format
71610-264
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
risperidone (source: ndc)
Generic Name
risperidone (source: ndc)
Application Number
ANDA201003 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/1
Packaging
- 15 TABLET in 1 BOTTLE (71610-264-15)
- 30 TABLET in 1 BOTTLE (71610-264-30)
- 45 TABLET in 1 BOTTLE (71610-264-45)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "734267df-c692-446a-ae8b-47462213b1ba", "openfda": {"nui": ["N0000175430"], "unii": ["L6UH7ZF8HC"], "rxcui": ["312831"], "spl_set_id": ["ac152803-d75f-4c3c-bc49-8663b21a3a82"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (71610-264-15)", "package_ndc": "71610-264-15", "marketing_start_date": "20190425"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71610-264-30)", "package_ndc": "71610-264-30", "marketing_start_date": "20190425"}, {"sample": false, "description": "45 TABLET in 1 BOTTLE (71610-264-45)", "package_ndc": "71610-264-45", "marketing_start_date": "20190425"}], "brand_name": "RISPERIDONE", "product_id": "71610-264_734267df-c692-446a-ae8b-47462213b1ba", "dosage_form": "TABLET", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "71610-264", "generic_name": "RISPERIDONE", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RISPERIDONE", "active_ingredients": [{"name": "RISPERIDONE", "strength": "2 mg/1"}], "application_number": "ANDA201003", "marketing_category": "ANDA", "marketing_start_date": "20140328", "listing_expiration_date": "20261231"}